Medpace Holdings, Inc.
MEDP
$592.01
-$9.37-1.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.24% | 26.50% | 32.03% | 23.74% | 14.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.24% | 26.50% | 32.03% | 23.74% | 14.24% |
| Cost of Revenue | 9.00% | 11.51% | 8.73% | 8.62% | 8.33% |
| Gross Profit | 20.91% | 33.51% | 42.60% | 30.90% | 17.09% |
| SG&A Expenses | 3.08% | -17.24% | -1.14% | -2.31% | 12.57% |
| Depreciation & Amortization | -4.33% | -0.35% | -5.00% | -6.24% | -3.05% |
| Other Operating Expenses | 27.65% | 54.15% | 68.27% | 43.50% | 17.14% |
| Total Operating Expenses | 17.51% | 26.98% | 35.01% | 23.05% | 12.77% |
| Operating Income | 16.22% | 24.65% | 22.25% | 26.31% | 20.15% |
| Income Before Tax | 21.78% | 24.90% | 17.14% | 20.26% | 12.72% |
| Income Tax Expenses | -11.60% | 563.52% | 28.68% | 41.84% | 54.89% |
| Earnings from Continuing Operations | 34.46% | 8.09% | 15.48% | 15.25% | 2.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.46% | 8.09% | 15.48% | 15.25% | 2.16% |
| EBIT | 16.22% | 24.65% | 22.25% | 26.31% | 20.15% |
| EBITDA | 15.14% | 23.21% | 20.71% | 24.26% | 18.65% |
| EPS Basic | 36.50% | 15.47% | 26.41% | 27.18% | 10.69% |
| Normalized Basic EPS | 23.62% | 33.43% | 28.13% | 32.70% | 22.14% |
| EPS Diluted | 37.10% | 16.62% | 26.94% | 28.24% | 12.73% |
| Normalized Diluted EPS | 24.30% | 34.53% | 28.91% | 33.91% | 24.10% |
| Average Basic Shares Outstanding | -1.49% | -6.39% | -8.58% | -9.38% | -7.71% |
| Average Diluted Shares Outstanding | -2.02% | -7.16% | -9.13% | -10.19% | -9.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |